drugset / Trial / NCT05306405

Comparative Study Between Only Vaginal Misoprostol and Vaginal Misoprostol and Estradiol Cream

NCT05306405

Phase 1/2 Unknown 120 enrolled Ain Shams University
RandomizedParallel-groupSingle-blindTreatment

Summary

To compare the safety and effectiveness of vaginal misoprostol with combined vaginal misoprostol and estradiol for induction of labour in unfavorable cervix

Timeline

Start
2022-02-20
Primary completion
2022-08-01
Completion
2022-08-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Estradiol Other / unclassified 150 ml Intrathecal
Comparator Misoprostol Other / unclassified 25 ug Intrathecal

Indications